NeurologyLive Friday 5 — October 30, 2020

October 30, 2020
NeurologyLive Staff
NeurologyLive Staff

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 30, 2020.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Telemedicine: An Opportunity to Bring Better Care to All

October 2020 issue guest editor in chief Jessica Ailani, MD, FAHS, FAAN, provides an overview of the challenges and benefits associated with telemedicine.

2: Why an Inclusive Patient Population Is Important for the Future of DMD Treatment

In this interview, Elias Kouchakji, MD, gives perspective on pamrevlumab’s unique pathway as a Duchenne muscular dystrophy treatment nearing the end of the clinical pipeline.

3: Anup Patel, MD: Challenges Associated With Lennox-Gastaut Syndrome

The section chief of pediatric neurology at Nationwide Children’s Hospital discusses some of the challenges that patients with Lennox-Gastaut syndrome and their caregivers face.

4: NeuroVoices: Jennifer Frontera, MD, on New COVID-19 Data

The professor of neurology at the NYU Langone Grossman School of Medicine discussed a recent study she and colleagues conducted on new neurological disorders in patients with COVID-19.

5: Joe Verghese, MBBS, MS: Characteristics of Motoric Cognitive Risk Syndrome

The director of the Montefiore Einstein Center for the Aging Brain detailed the symptoms of motoric cognitive risk syndrome and how they compare to more typical mild cognitive impairment.